Does Isturisa 10 Mg Tablet Adrenal Steroid Inhibitors Interact with other Medications?
Severe Interactions
These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- CYP1A2 INHIBITORS/FEZOLINETANT
- WEAK CYP3A4 INHIBITORS/LEMBOREXANT (> 5 MG)
- SELECTED CYP1A2 INHIBITORS/RASAGILINE (> 0.5 MG)
- WEAK CYP3A4 INHIBITORS/LOMITAPIDE (>30 MG)
Serious Interactions
These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- OSILODROSTAT/STRONG CYP3A4 INHIBITORS THAT PROLONG QT
- OSILODROSTAT/LONAFARNIB
- WEAK CYP2C19 INHIBITORS/MAVACAMTEN
- SLT CYP2C19 INHIBITORS THAT PROLONG QT/CITALOPRAM (>20 MG)
- WEAK CYP3A4 INHIBITORS/ELIGLUSTAT
- AGENTS AFFECTING PLASMA CORTISOL LEVELS/COSYNTROPIN
- POSSIBLE QT PROLONGING AGENTS/DOMPERIDONE
- POSSIBLE QT PROLONGING AGENTS/ANAGRELIDE
- WEAK CYP3A4 INHIBITORS/LOMITAPIDE (<=30MG)
- SELECTED CYP2C19 INHIBITORS/CLOPIDOGREL
- POSSIBLE QT PROLONGING AGENTS/DRONEDARONE
- POSSIBLE QT PROLONGING AGENTS/ARTEMETHER-LUMEFANTRINE
- POSSIBLE QT PROLONGING AGENTS/DISOPYRAMIDE
- POSSIBLE QT PROLONGING AGENTS/CISAPRIDE
- SELECTED QT PROLONGING AGENTS/ZIPRASIDONE
- POSSIBLE QT PROLONGING AGENTS/SERTINDOLE
- POSSIBLE QT PROLONGING AGENTS/DROPERIDOL
- POSSIBLE QT PROLONGING AGENTS/LEVOMETHADYL
- POSSIBLE QT PROLONGING AGENTS/SPARFLOXACIN
- POSSIBLE QT PROLONGING AGENTS/HALOFANTRINE
- POSSIBLE QT PROLONGING AGENTS/PIMOZIDE
- POSSIBLE QT PROLONGING AGENTS/BEPRIDIL
Moderate Interactions
These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- OSILODROSTAT/STRONG CYP3A4 INHIBITORS
- OSILODROSTAT/QT PROLONGING AGENTS
- POSSIBLE QT PROLONGING AGENTS/DEXMEDETOMIDINE SUBLINGUAL
- QT PROLONGING AGENTS/ETRASIMOD
- QT PROLONGING AGENTS/GEPIRONE
- POSSIBLE QT PROLONGING AGENTS/QUIZARTINIB
- QT PROLONGING AGENTS/TUCIDINOSTAT
- QT PROLONGING AGENTS/SAVOLITINIB
- SLT CYP2C19 INHIB THAT PROLONG QT/ESCITALOPRAM (<= 15 MG)
- SLT CYP2C19 INHIB THAT PROLONG QT/ESCITALOPRAM (> 15 MG)
- SLT CYP2C19 INHIBITORS THAT PROLONG QT/CITALOPRAM (<= 20 MG)
- QT PROLONGING AGENTS/TRICLABENDAZOLE
- POSSIBLE QT PROLONGING AGENTS/PACRITINIB
- SLT MODERATE AND WEAK CYP3A4 INHIBIT/SIROLIMUS PROTEIN-BOUND
- POSSIBLE QT PROLONGING AGENTS/MOBOCERTINIB
- QT PROLONGING AGENTS/OZANIMOD
- QT PROLONGING AGENTS/PONESIMOD
- QT PROLONGING AGENTS/SIPONIMOD
- POSSIBLE QT PROLONGING AGENTS/FEXINIDAZOLE
- QT PROLONGING AGENTS/GALANTAMINE
- POSSIBLE QT PROLONGING AGENTS/LEVOMEPROMAZINE
- POSSIBLE QT PROLONGING AGENTS/SELPERCATINIB
- OSILODROSTAT/TIZANIDINE
- OSILODROSTAT/CLOZAPINE
- OSILODROSTAT/SELECTED CYP1A2 SUBSTRATES
- WEAK CYP3A4 INHIBITORS/UBROGEPANT
- WEAK CYP3A4 INHIBITORS/LEMBOREXANT (<= 5 MG)
- MODERATE & WEAK CYP3A4 INHIBITORS THAT PROLONG QT/TACROLIMUS
- POSSIBLE QT PROLONGING AGENTS/HYDROXYCHLOROQUINE
- MODERATE CYP1A2 INHIBITORS/PIRFENIDONE
- QT PROLONGING AGENTS/FINGOLIMOD
- POSSIBLE QT PROLONGING AGENTS/GADOFOSVESET
- SELECTED CYP2D6 INHIBITORS/METOPROLOL
- SELECTED CYP1A2 INHIBITORS/RASAGILINE (<= 0.5 MG)
- SELECTED WEAK CYP2D6 INHIBITORS/TAMOXIFEN
- POSSIBLE QT PROLONGING AGENTS/THIORIDAZINE
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.